文献速递认知障碍与痴呆

唐氏综合征成人阿尔茨海默病的代谢物特征

Metabolite Signature of Alzheimer's Disease in Adults with Down Syndrome.
PubMed 文献 · Ann Neurol · 2021-08-06

研究纳入118名唐氏综合征成人和71名整倍体健康对照,用磁共振波谱检测楔前叶肌醇和N-乙酰天冬氨酸水平。无症状唐氏成人肌醇较对照升高27.5%,随疾病进展肌醇升高、N-乙酰天冬氨酸在症状期下降,两者与阿尔茨海默病生物标志物及皮质厚度相关。

要点

  • 无症状唐氏成人已出现肌醇升高27.5%,提示早期神经炎症。
  • 肌醇随疾病进展升高,N-乙酰天冬氨酸仅在症状期下降。
  • 两种代谢物与淀粉样蛋白、tau、神经变性和皮质变薄相关。

核心结论

  • 磁共振波谱可检测唐氏综合征中阿尔茨海默病相关的炎症和神经变性,可能作为无创疾病分期生物标志物。

研究设计与样本

  • 研究纳入118名唐氏综合征成人(来自Down Alzheimer Barcelona Imaging Initiative)和71名整倍体健康对照(来自Sant Pau Initiative on Neurodegeneration队列)。
  • 采用磁共振波谱测量楔前叶肌醇(神经炎症标志物)和N-乙酰天冬氨酸(神经元完整性标志物)水平。

主要发现

  • 无症状唐氏综合征成人肌醇水平较整倍体健康对照升高27.5%,N-乙酰天冬氨酸水平相等。
  • 随疾病进展,肌醇水平升高,而N-乙酰天冬氨酸在症状期下降。
  • 肌醇主要在有症状阶段与淀粉样蛋白、tau和神经变性标志物相关,N-乙酰天冬氨酸在症状期与神经变性生物标志物相关。
  • 两种代谢物均与皮质变薄显著相关,主要在有症状参与者中。

临床怎么用

  • 磁共振波谱检测楔前叶肌醇和N-乙酰天冬氨酸可能用于唐氏综合征阿尔茨海默病的无创分期评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The purpose of this study was to examine the Alzheimer's disease metabolite signature through magnetic resonance spectroscopy in adults with Down syndrome and its relation with Alzheimer's disease biomarkers and cortical thickness. METHODS: We included 118 adults with Down syndrome from the Down Alzheimer Barcelona Imaging Initiative and 71 euploid healthy controls from the Sant Pau Initiative on Neurodegeneration cohort. We measured the levels of myo-inositol (a marker of neuroinflammation) and N-acetyl-aspartate (a marker of neuronal integrity) in the precuneus using magnetic resonance spectroscopy. We investigated the changes with age and along the disease continuum (asymptomatic, prodromal Alzheimer's disease, and Alzheimer's disease dementia stages). We assessed the relationship between these metabolites and Aβ42 /Aβ40 ratio, phosphorylated tau-181, neurofilament light (NfL), and YKL-40 cerebrospinal fluid levels as well as amyloid positron emission tomography uptake using Spearman correlations controlling for multiple comparisons. Finally, we computed the relationship between cortical thickness and metabolite levels using Freesurfer. RESULTS: Asymptomatic adults with Down syndrome had a 27.5% increase in the levels of myo-inositol, but equal levels of N-acetyl-aspartate compared to euploid healthy controls. With disease progression, myo-inositol levels increased, whereas N-acetyl-aspartate levels decreased in symptomatic stages of the disease. Myo-inositol was associated with amyloid, tau, and neurodegeneration markers, mainly at symptomatic stages of the disease, whereas N-acetyl-aspartate was related to neurodegeneration biomarkers in symptomatic stages. Both metabolites were significantly associated with cortical thinning, mainly in symptomatic participants. INTERPRETATION: Magnetic resonance spectroscopy detects Alzheimer's disease related inflammation and neurodegeneration, and could be a good noninvasive disease-stage biomarker in Down syndrome. ANN NEUROL 2021;90:407-416.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Montal V, Barroeta I, Bejanin A, et al. Metabolite Signature of Alzheimer's Disease in Adults with Down Syndrome. Ann Neurol. 2021. PMID: 34309066. doi:10.1002/ana.26178

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。